Alterity Therapeutics Limited (ATH.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 03:57PM AEDT
| Previous close | 0.0070 |
| Open | 0.0070 |
| Bid | 0.0070 x 59129200 |
| Ask | 0.0070 x 100647600 |
| Day's range | 0.0060 - 0.0070 |
| 52-week range | 0.0030 - 0.0110 |
| Volume | |
| Avg. volume | 9,126,447 |
| Market cap | 14.639M |
| Beta (5Y monthly) | 0.56 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Alterity (ATHE) Up on Preclinical Parkinson's Treatment Data
Data from a preclinical study shows that treatment with Alterity's (ATHE) lead candidate improved motor performance and general function in monkeys with experimentally-induced Parkinson's disease.
- Simply Wall St.
Alterity Therapeutics Limited's (ASX:ATH) CEO Compensation Is Looking A Bit Stretched At The Moment
Key Insights Alterity Therapeutics' Annual General Meeting to take place on 28th of November CEO David Stamler's total...
- Zacks
Is Vir Biotechnology (VIR) Outperforming Other Medical Stocks This Year?
Here is how Vir Biotechnology, Inc. (VIR) and Prana Biotechnology Ltd (ATHE) have performed compared to their sector so far this year.
© 2023 Yahoo. All rights reserved.